Copper, iron and zinc in Alzheimer's disease senile plaques

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported

Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627

Rapid induction of Alzheimer A beta amyloid formation by zinc

Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296

Release of endogenous Zn2+ from brain tissue during activity

Assaf, S. Y., & Chung, S. (1984) · Nature · doi:10.1038/308734a0 · Cited by 1,113

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086

Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance

Jiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y., & Zhou, F. (2007) · Biochemistry · doi:10.1021/bi700508n · Cited by 204

Novel -penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases

Cui, Z., Lockman, P. R., Atwood, C., Hsu, C. C., Gupte, A., ALLEN, D., & Mumper, R. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.07.009 · Cited by 203

The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators

Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200

Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease

Guo, C., Wang, T., Zheng, W. H., Shan, Z., Teng, W., & Wang, Z. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.009 · Cited by 200

Distinct Effects of Zn2+, Cu2+, Fe3+, and Al3+ on Amyloid-β Stability, Oligomerization, and Aggregation

Chen, W.-T., Liao, Y., Yu, H.-M., Cheng, I. H.-J., & Chen, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177246 · Cited by 199

Copper Binding to the Octarepeats of the Prion Protein

Garnett, A. P., & Viles, J. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209280200 · Cited by 200

Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-β from Alzheimer Disease

Sarell, C. J., Wilkinson, S. R., & Viles, J. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171355 · Cited by 199

Nanotechnology—novel therapeutics for CNS disorders

Srikanth, M., & Kessler, J. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.76 · Cited by 198

Molecular-Level Examination of Cu2+ Binding Structure for Amyloid Fibrils of 40-Residue Alzheimer’s β by Solid-State NMR Spectroscopy

Parthasarathy, S., Long, F., Miller, Y., Xiao, Y., McElheny, D., Thurber, K. R., Ma, B., Nussinov, R., & Ishii, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1072178 · Cited by 200

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

Jack, C. R., Garwood, M., Wengenack, T. M., Borowski, B., Curran, G. L., Lin, J., Adriany, G., Gröhn, O. H. J., Grimm, R. C., & Poduslo, J. F. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20266 · Cited by 196

Iron(II) Binding to Amyloid-β, the Alzheimer’s Peptide

Garah, F. E., Bijani, C., Coppel, Y., Faller, P., & Hureau, C. (2011) · Inorganic Chemistry · doi:10.1021/ic201233b · Cited by 199

Mitochondrial Iron in Human Health and Disease

Ward, D. M., & Cloonan, S. M. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114742 · Cited by 208

Mitochondrial iron metabolism and its role in neurodegeneration

Horowitz, M. P., & Greenamyre, J. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100354 · Cited by 195

Concentration Dependent Cu2+Induced Aggregation and Dityrosine Formation of the Alzheimer's Disease Amyloid-β Peptide

Smith, D. P., Ciccotosto, G. D., Tew, D. J., Fodero‐Tavoletti, M. T., Johanssen, T., Masters, C. L., Barnham, K. J., & Cappai, R. (2007) · Biochemistry · doi:10.1021/bi0620961 · Cited by 193

Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration

Rojas-Gutierrez, E., Muñoz‐Arenas, G., Treviño, S., Espinosa, B., Chávez, R., Rojas, K., Flores, G., Díaz, A., & Guevara, J. (2017) · Synapse · doi:10.1002/syn.21990 · Cited by 205

The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer’s Disease

Habtemariam, S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/2680409 · Cited by 195

Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain

Guo, C., Wang, P., Zhong, M., Wang, T., Huang, X., Li, J., & Wang, Z. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.005 · Cited by 192

Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation

Barnham, K. J., Ciccotosto, G. D., Tickler, A. K., Ali, F. E. A., Smith, D. G., Williamson, N. A., Lam, Y.-H., Carrington, D., Tew, D. J., Kocak, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305494200 · Cited by 191

Two-Dimensional Structure of β-Amyloid(10−35) Fibrils

Benzinger, T. L. S., Gregory, D. M., Burkoth, T. S., Miller-Auer, H., Lynn, D. G., Botto, R. E., & Meredith, S. C. (2000) · Biochemistry · doi:10.1021/bi991527v · Cited by 188

Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322

Mo, Z., Zhu, Y.-Z., Zhu, H., Fan, J.-B., Chen, J., & Liang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058883 · Cited by 193

S100 Proteins in Alzheimer’s Disease

Cristóvão, J. S., & Gomes, C. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00463 · Cited by 188

Selective Translational Control of the Alzheimer Amyloid Precursor Protein Transcript by Iron Regulatory Protein-1

Cho, H.-H., Cahill, C. M., Vanderburg, C. R., Scherzer, C. R., Wang, B., Huang, X., & Rogers, J. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149161 · Cited by 188

Overview of Alzheimer’s Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds

Singh, S. K., Srivastav, S., Yadav, A. K., Srikrishna, S., & Perry, G. L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7361613 · Cited by 196

Three Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and Iron

Nakamura, M., Shishido, N., Nunomura, A., Smith, M. A., Perry, G. L., Hayashi, Y., Nakayama, K., & Hayashi, T. (2007) · Biochemistry · doi:10.1021/bi701079z · Cited by 184

Metal ions as modulators of protein conformation and misfolding in neurodegeneration

Leal, S. S., Botelho, H. M., & Gomes, C. M. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.004 · Cited by 187

Nanomaterials for Reducing Amyloid Cytotoxicity

Zhang, M., Mao, X., Yu, Y., Wang, C.-X., Yang, Y., & Wang, C. (2013) · Advanced Materials · doi:10.1002/adma.201301210 · Cited by 183

A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s disease

Al‐Hilaly, Y. K., Williams, T. L., Stewart-Parker, M., Ford, L. K., Skaria, E., Cole, M., Bucher, W. G., Morris, K. L., Sada, A. A., Thorpe, J. R., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-83 · Cited by 187

Effects of in vivo conditions on amyloid aggregation

Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 181

Amyloid Precursor Proteins Inhibit Heme Oxygenase Activity and Augment Neurotoxicity in Alzheimer's Disease

Takahashi, M., Doré, S., Ferris, C. D., Tomita, T., Sawa, A., Wolosker, H., Borchelt, D., Iwatsubo, T., Kim, S., Thinakaran, G., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00125-2 · Cited by 183

Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

Butterfield, D. A., Debra Boyd-kimball, A., & Castegna, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01948.x · Cited by 181

Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease

Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A., & Zhu, X. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9360-7 · Cited by 180

Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies

Bucossi, S., Ventriglia, M., Panetta, V., Salustri, C., Pasqualetti, P., Mariani, S., Siotto, M., Rossini, P. M., & Squitti, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101473 · Cited by 186

Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators

Tõugu, V., Karafin, A., Zovo, K., Chung, R. S., Howells, C., West, A. K., & Palumaa, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06269.x · Cited by 181

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau

Squitti, R., Barbati, G., Rossi, L. C., Ventriglia, M., Forno, G. D., Cesaretti, S., Moffa, F., Caridi, I., Cassetta, E., Pasqualetti, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000223343.82809.cf · Cited by 180

Protein nitration is mediated by heme and free metals through Fenton-type chemistry: An alternative to the NO/O\documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy}\usepackage{mathrsfs}\setlength{\oddsidemargin}{-69pt}\begin{document}\begin{equation*}{\mathrm{_{2}^{-}}}\end{equation*}\end{document} reaction

Thomas, D. D., Espey, M. G., Vitek, M. P., Miranda, K. M., & Wink, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202312699 · Cited by 181

Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma

Kontush, A., Berndt, C., Weber, W., Akopyan, V., Arlt, S., Schippling, S., & Beisiegel, U. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00458-5 · Cited by 180

Neurotoxicity of Metal Mixtures

Andrade, V. M., Aschner, M., & dos Santos, A. P. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_12 · Cited by 180

Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease

Lakey‐Beitia, J., Burillo, A., Penna, G. L., Hegde, M. L., & Rao, K. S. J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200185 · Cited by 193

The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease

Raha, A. A., Vaishnav, R., Friedland, R. P., Bomford, A. B., & Raha‐Chowdhury, R. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-55 · Cited by 183

Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 1: An overview

Hureau, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.037 · Cited by 183

Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance

Liu, G., Men, P., Harris, P. L. R., Rolston, R. K., Perry, G. L., & Smith, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.020 · Cited by 177

Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling

Ackerman, C. M., Lee, S., & Chang, C. J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04631 · Cited by 178

Oxidative Stress Gated by Fenton and Haber Weiss Reactions and Its Association With Alzheimer’s Disease

Kanti Das, T., Wati, M. R., & Fatima-Shad, K. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.20078 · Cited by 177

Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease

Kontush, A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00688-8 · Cited by 178

Advances in the Understanding of Mammalian Copper Transporters

Wang, Y., Hodgkinson, V. L., Zhu, S., Weisman, G. A., & Petris, M. J. (2011) · Advances in Nutrition · doi:10.3945/an.110.000273 · Cited by 177

Zinc Signal in Brain Diseases

Portbury, S. D., & Adlard, P. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122506 · Cited by 175

Carbonic anhydrase gating of attention: memory therapy and enhancement

Sun, M., & Alkon, D. L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01899-0 · Cited by 175

Site-Specific Interactions of Cu(II) with α and β-Synuclein: Bridging the Molecular Gap between Metal Binding and Aggregation

Binolfi, A., Lamberto, G. R., Durán, R., Quintanar, L., Bertoncini, C. W., Souza, J. M., Červeñanský, C., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803494v · Cited by 173

Nanotechnological applications for the treatment of neurodegenerative disorders

Modi, G., Pillay, V., Choonara, Y. E., Ndesendo, V. M. K., du Toit, L. C., & Naidoo, D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.05.002 · Cited by 174

Nanoscale biogenic iron oxides and neurodegenerative disease

Dobson, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02386-9 · Cited by 171

Cortical iron reflects severity of Alzheimer's disease

van Duijn, S., Bulk, M., van Duinen, S. G., Nabuurs, R. J. A., van Buchem, M. A., van der Weerd, L., & Natté, R. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161143 · Cited by 172

NMR Reveals Anomalous Copper(II) Binding to the Amyloid Aβ Peptide of Alzheimer's Disease

Hou, L., & Zagorski, M. G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja046032u · Cited by 169

Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer’s Disease

Li, Y. H., Jiao, Q., Xu, H., Du, X., Shi, L., Jia, F., & Jiang, H. F. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00339 · Cited by 173

Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance

Atrián‐Blasco, E., Gonzalez, P., Santoro, A., Aliès, B., Faller, P., & Hureau, C. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.04.007 · Cited by 175

Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Aβ) of Alzheimer's disease

Syme, C. D., & Viles, J. H. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.09.012 · Cited by 167

Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease

Hegde, M. L., Bharathi, P., Suram, A., Venugopal, C., Jagannathan, R., Poddar, P., Srinivas, P., Sambamurti, K., Rao, K. S. J., Ščančar, J., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1068 · Cited by 167

Astroglia as Metal Depots: Molecular Mechanisms for Metal Accumulation, Storage and Release

Tiffany‐Castiglioni, E., & Qian, Y. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00050-x · Cited by 166

Alanine-2 Carbonyl is an Oxygen Ligand in Cu 2+ Coordination of Alzheimer’s Disease Amyloid-β Peptide − Relevance to N-Terminally Truncated Forms

Drew, S. C., Masters, C. L., & Barnham, K. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903669a · Cited by 166

Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration

Finazzi, D., & Arosio, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1329-0 · Cited by 166

Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD

Kitazawa, M., Cheng, D., & LaFerla, F. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05901.x · Cited by 165

Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents

Mandel, S., Amit, T., Bar-Am, O., & Youdim, M. B. H. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.001 · Cited by 164

The Molecular Basis of Copper Homeostasis Copper-Related Disorders

Llanos, R. M., & Mercer, J. F. B. (2002) · DNA and Cell Biology · doi:10.1089/104454902753759681 · Cited by 165

Advances in the treatment of neurodegenerative disorders employing nanotechnology

Modi, G., Pillay, V., & Choonara, Y. E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05108.x · Cited by 166

Localization of copper and copper transporters in the human brain

Davies, K. M., Hare, D. J., Cottam, V., Chen, N., Hilgers, L., Halliday, G. M., Mercer, J. F. B., & Double, K. L. (2012) · Metallomics · doi:10.1039/c2mt20151h · Cited by 163

Inflammation, Neurodegenerative Diseases, and Environmental Exposures

Campbell, A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.008 · Cited by 166

Tailoring tripodal ligands for zinc sensing

Dai, Z., & Canary, J. W. (2007) · New Journal of Chemistry · doi:10.1039/b710803f · Cited by 163

Copper: from neurotransmission to neuroproteostasis

Opazo, C., Greenough, M. A., & Bush, A. I. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00143 · Cited by 159

Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease

Axelsen, P. H., Komatsu, H., & Murray, I. V. J. (2011) · Physiology · doi:10.1152/physiol.00024.2010 · Cited by 159

Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid β Peptide

Raman, B., Ban, T., Yamaguchi, K., Sakai, M., Kawai, T., Naiki, H., & Goto, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500309200 · Cited by 158

Quinoline‐n‐butylcyanoacrylate‐based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease

Kulkarni, P. V., Roney, C. A., Antich, P. P., Bonte, F. J., Raghu, A. V., & Aminabhavi, T. M. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.59 · Cited by 161

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 160

Mitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance

Rossi, L. C., Lombardo, M. F., Ciriolo, M. R., & Rotilio, G. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014820.99232.8a · Cited by 158

Metal Ion Physiopathology in Neurodegenerative Disorders

Bolognin, S., Luigi Messori, A., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 159

Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer’s disease: Limitations, and current and future perspectives

Fasae, K. D., Abolaji, A. O., Faloye, T. R., Odunsi, A., Oyetayo, B. O., Enya, J. I., Rotimi, J. A., Akinyemi, R., Whitworth, A. J., & Aschner, M. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126779 · Cited by 161

Copper deficiency and neurological disorders in man and animals

Zatta, P. F., & Frank, A. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.10.001 · Cited by 159

Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease

Gupta, J., Fatima, M. T., Islam, Z., Khan, R. H., Uversky, V. N., & Salahuddin, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.156 · Cited by 163

Synthesis, Characterization, and Metal Coordinating Ability of Multifunctional Carbohydrate-Containing Compounds for Alzheimer's Therapy

Storr, T., Merkel, M., Song-Zhao, G. X., Scott, L. E., Green, D. E., Bowen, M. L., Thompson, K. H., Patrick, B. O., Schugar, H. J., & Orvig, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068965r · Cited by 156

Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid

Altschul, D., Launer, L. J., Adlard, P. A., Cherny, R. A., Tsatsanis, A., Volitakis, I., Blennow, K., Petrovitch, H., White, L. R., & Bush, A. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.012 · Cited by 154

Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting β-Amyloid Burden

Malm, T., Iivonen, H., Goldsteins, G., Keksa-Goldsteine, V., Ahtoniemi, T., Kanninen, K. M., Salminen, A., Auriola, S. O. K., van Groen, T., Tanila, H., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0059-07.2007 · Cited by 157

Probing Copper2+ Binding to the Prion Protein Using Diamagnetic Nickel2+ and 1H NMR: The Unstructured N terminus Facilitates the Coordination of Six Copper2+ Ions at Physiological Concentrations

Jones, C. E., Klewpatinond, M., Abdelraheim, S. R., Brown, D. R., & Viles, J. H. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.12.043 · Cited by 154

Metal Dyshomeostasis and Inflammation in Alzheimer’s and Parkinson’s Diseases: Possible Impact of Environmental Exposures

Myhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 154

Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders

Mena, N. P., Urrutia, P. J., Lourido, F., Carrasco, C. M., & Núñez, M. T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.001 · Cited by 154

The molecular and cellular basis of copper dysregulation and its relationship with human pathologies

Maung, M. T., Carlson, A., Olea‐Flores, M., Elkhadragy, L., Schachtschneider, K. M., Navarro‐Tito, N., & Padilla‐Benavides, T. (2021) · The FASEB Journal · doi:10.1096/fj.202100273rr · Cited by 158

Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease

Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 155

Liberation of Copper from Amyloid Plaques: Making a Risk Factor Useful for Alzheimer’s Disease Treatment

Geng, J., Li, M. C., Wu, L. J., Ren, J., & Qu, X. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003813 · Cited by 153

Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1–42)

Everett, J. L., Céspedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J., van der Laan, G., Jenkins, C., Arenholz, E., & Telling, N. D. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0165 · Cited by 156

Exosomes in Alzheimer's disease

Malm, T., Loppi, S. H., & Kanninen, K. M. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.04.011 · Cited by 152

Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease

Zeineh, M. M., Chen, Y., Kitzler, H. H., Hammond, R., Vogel, H., & Rutt, B. K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.022 · Cited by 151

Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase

Harris, F. M., Brecht, W. J., Xu, Q., Mahley, R. W., & Huang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408127200 · Cited by 151

The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151

Quantitative MR Phase-corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer Disease

Zhu, W., Zhong, W., Wang, W., Zhan, C., Wang, C., Jianpin, Q., Wang, J., & Lei, T. (2009) · Radiology · doi:10.1148/radiol.2532082324 · Cited by 151

Alzheimer’s disease: How metal ions define β-amyloid function

Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154

The Role of Zinc in Alzheimer′s Disease

Watt, N. T., Whitehouse, I. J., & Hooper, N. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/971021 · Cited by 148

Targeting Multiple Neurodegenerative Diseases Etiologies with Multimodal-Acting Green Tea Catechins

Mandel, S. A., Amit, T., Kalfon, L., Reznichenko, L., & Youdim, M. B. H. (2008) · Journal of Nutrition · doi:10.1093/jn/138.8.1578s · Cited by 147

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease

Unzeta, M., Esteban, G., Bolea, I., Fogel, W. A., Ramsay, R. R., Youdim, M. B. H., Tipton, K. F., & Marco, J. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00205 · Cited by 154

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage

Farr, A. C., & Xiong, M. P. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00474 · Cited by 154

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease

Rogers, J. T., Bush, A. I., Cho, H.-H., Smith, D. H., Thomson, A. M., Friedlich, A. L., Lahiri, D. K., Leedman, P. J., Huang, X., & Cahill, C. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361282 · Cited by 148

Binding of Zn(II), Cu(II), and Fe(II) ions to alzheimer's Aß peptide studied by fluorescence

Garzon-Rodriguez, W., Yatsimirsky, A. K., & Glabe, C. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00357-1 · Cited by 148

Three-Dimensional Tomographic Imaging and Characterization of Iron Compounds within Alzheimer's Plaque Core Material

Collingwood, J. F., Chong, R. K. K., Kasama, T., Cervera-Gontard, L., Dunin-Borkowski, R. E., Perry, G., Pósfai, M., Siedlak, S. L., Simpson, E. T., Smith, M. A., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14211 · Cited by 147

Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease

Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146

Zinc and Alzheimer's Disease: An Update

Cuajungco, M. P., Lees, G. J., Kydd, R. R., Tanzi, R. E., & Bush, A. I. (1999) · Nutritional Neuroscience · doi:10.1080/1028415x.1999.11747277 · Cited by 6

Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer’s Disease Correlates with Metal Levels in the Surrounding Neuropil

James, S., Churches, Q. I., de Jonge, M. D., Birchall, I. E., Streltsov, V. A., McColl, G., Adlard, P. A., & Hare, D. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00362 · Cited by 136

Elevated cortical zinc in Alzheimer disease

Religa, D., Strozyk, D., Cherny, R. A., Volitakis, I., Haroutunian, V., Winblad, B. G., Näslund, J., & Bush, A. I. (2006) · Neurology · doi:10.1212/01.wnl.0000223644.08653.b5 · Cited by 273

Association of trace elements Aluminum, Copper and Zinc in blood of Alzheimer's disease

Anwar, M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70860_107018

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress.

Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540